Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Blast Crisis × lenvatinib × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Neoplasms 8 Carcinoma, Hepatocellular 8 Thyroid Neoplasms 5 Melanoma 5 Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Cancer, Papillary 3 Colorectal Neoplasms 3 Adenocarcinoma, Follicular 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Lymphoma 2 Glioma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, medullary 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1

Interventions

fludarabine phosphate 23 Cyclophosphamide 22 Busulfan 19 Whole-Body Irradiation 18 Peripheral Blood Stem Cell Transplantation 18 Mycophenolic Acid 17 Tacrolimus 13 Cyclosporine 12 Antilymphocyte Serum 12 Methotrexate 10 Melphalan 9 Filgrastim 8 Cytarabine 8 Etoposide 7 Cord Blood Stem Cell Transplantation 7 fludarabine 6 Methylprednisolone 6 Granulocyte Colony-Stimulating Factor 5 thymoglobulin 4 Thiotepa 4 Sirolimus 4 Rituximab 4 Radiotherapy 4 Imatinib Mesylate 4 Flow Cytometry 4 Dexamethasone 4 Cyclosporins 4 Calcium Dobesilate 4 dexamethasone acetate 3 dexamethasone 21-phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡